Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Capraro, J. A.
Right arrow Articles by Little, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Capraro, J. A.
Right arrow Articles by Little, J. R.

Stroke, Vol 15, 486-491, Copyright © 1984 by American Heart Association


ARTICLES

Treatment of acute focal cerebral ischemia with propranolol

JA Capraro, DP Reedy, JP Latchaw, RM Slugg, NT Stowe, RP Lesser and JR Little

Propranolol's potential as a protective agent against tissue injury has been noted in experimental myocardial, renal and early acute focal cerebral ischemia. The purpose of the present investigation was to study further the effects of racemic (d,l) propranolol on blood-brain barrier permeability, morphological changes, cortical electrical activity, and regional cerebral blood flow (rCBF) in experimental focal cerebral ischemia. Thirty adult cats, anesthetized with nitrous oxide, underwent 6 hours of right middle cerebral artery (MCA) occlusion. Fifteen cats were untreated. Fifteen cats were given a continuous infusion of racemic propranolol (1 mg/kg/hr) for 7 hours beginning 1 hour before MCA occlusion and a 4 mg/kg bolus immediately before occlusion, both directly into the right carotid artery. Right Sylvian rCBF did not significantly differ in the treated and untreated groups. Carbon filling defects and vital dye (i.e., Evans blue and fluorescein) extravasation were less severe in the propranolol treated animals. Light microscopic findings demonstrated no difference in infarct size between the two groups. The findings suggest that at doses given, racemic propranolol does not exert a protective effect upon cerebral tissue subjected to 6 hours of incomplete ischemia.


This article has been cited by other articles:


Home page
Anesth. Analg.Home page
R.-Q. Han, Y.-B. Ouyang, L. Xu, R. Agrawal, A. J. Patterson, and R. G. Giffard
Postischemic Brain Injury Is Attenuated in Mice Lacking the {beta}2-Adrenergic Receptor
Anesth. Analg., January 1, 2009; 108(1): 280 - 287.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
T. Goyagi, T. Kimura, T. Nishikawa, Y. Tobe, and Y. Masaki
{beta}-Adrenoreceptor Antagonists Attenuate Brain Injury After Transient Focal Ischemia in Rats.
Anesth. Analg., September 1, 2006; 103(3): 658 - 663.
[Abstract] [Full Text] [PDF]